# Joe Rogan Praises Trump’s Executive Order on Psychedelic Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychedelic-research-funding-impact-trump-executive-order/ > **Published:** 2026-04-19T07:05:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:18:10-04:00 > **Clinical Summary:** Explore how psychedelic research funding influences clinical trials and therapy access under Trump's executive order. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PsychedelicsPtsdDepressionPolicy[Clinical Trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) Why This Matters Federal policy shifts on psychedelic research funding and regulatory pathways directly impact clinical trial access and timeline to therapeutic availability. For clinicians treating treatment-resistant depression, PTSD, and other conditions with limited options, policy acceleration could meaningfully expand the evidence base and treatment armamentarium. Clinical Summary While specific details of the referenced executive order are not provided in this summary, federal support for psychedelic research typically involves expanded NIH funding, streamlined FDA pathways, and reduced regulatory barriers for [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). Current evidence shows promising efficacy for psilocybin in treatment-resistant depression and MDMA in PTSD, though both require specialized clinical protocols and monitoring. The clinical application of psychedelics necessitates controlled settings, trained practitioners, and structured therapeutic frameworks rather than recreational use models. Dr. Caplan’s Take “Policy enthusiasm doesn’t change the fundamental clinical reality: psychedelics require rigorous therapeutic frameworks, not casual application. I’m watching for how implementation actually translates to expanded access for patients who’ve exhausted conventional treatments.” Clinical Perspective 🧠 Clinicians should distinguish between policy announcements and actual therapeutic availability, which remains years away for most indications. For patients with treatment-resistant conditions, this may signal eventual expanded options but shouldn’t delay current evidence-based treatments. Monitor developments in clinical trial access and specialized training requirements for therapeutic psychedelic administration. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Joe%20Rogan%20praises%20Trump%27s%20executive%20order%20on%20psychedelics%20research%20%7C%20Watch%20-%20MSN%20%40drcaplan&url=https%3A//www.msn.com/en-xl/news/other/joe-rogan-praises-trump-s-executive-order-on-psychedelics-research/vi-AA21dlUe%3Fcvid%3Ddb594f7d9ba64b3db3cbca5c45aa66b1)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.msn.com/en-xl/news/other/joe-rogan-praises-trump-s-executive-order-on-psychedelics-research/vi-AA21dlUe%3Fcvid%3Ddb594f7d9ba64b3db3cbca5c45aa66b1)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Joe%20Rogan%20praises%20Trump%27s%20executive%20order%20on%20psychedelics%20research%20%7C%20Watch%20-%20MSN%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.msn.com/en-xl/news/other/joe-rogan-praises-trump-s-executive-order-on-psychedelics-research/vi-AA21dlUe%3Fcvid%3Ddb594f7d9ba64b3db3cbca5c45aa66b1)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.msn.com/en-xl/news/other/joe-rogan-praises-trump-s-executive-order-on-psychedelics-research/vi-AA21dlUe?cvid=db594f7d9ba64b3db3cbca5c45aa66b1](https://www.msn.com/en-xl/news/other/joe-rogan-praises-trump-s-executive-order-on-psychedelics-research/vi-AA21dlUe?cvid=db594f7d9ba64b3db3cbca5c45aa66b1) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this psychedelics news?](#What_is_the_clinical_relevance_rating_for_this_psychedelics_news) - [What conditions are being studied with psychedelics according to this update?](#What_conditions_are_being_studied_with_psychedelics_according_to_this_update) - [Is this article focused on clinical research or policy developments?](#Is_this_article_focused_on_clinical_research_or_policy_developments) - [What makes this psychedelics news clinically significant?](#What_makes_this_psychedelics_news_clinically_significant) - [Is this related to cannabis or psychedelics specifically?](#Is_this_related_to_cannabis_or_psychedelics_specifically) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this psychedelics news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests emerging findings or policy developments that are worth monitoring closely by [healthcare professionals](https://cedclinic.com/women-reproductive-health-cannabis-applications/). #### What conditions are being studied with psychedelics according to this update? Based on the article tags, the primary conditions being addressed include PTSD and depression. These represent two of the most researched therapeutic applications for psychedelic treatments in clinical settings. #### Is this article focused on clinical research or policy developments? The article appears to cover both clinical and policy aspects, as indicated by the “Policy” tag alongside the medical condition tags. This suggests the news involves regulatory or legislative developments affecting psychedelic medicine. #### What makes this psychedelics news clinically significant? The “Notable Clinical Interest” designation indicates this involves emerging findings or policy changes that could impact [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). Such developments are considered important enough for healthcare providers to monitor closely for potential implications. #### Is this related to cannabis or psychedelics specifically? While published under “Cannabis News,” the primary focus is on psychedelics as indicated by the main topic tag. This suggests coverage of psychedelic medicine developments within a broader cannabis and [alternative medicine](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) news context. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [President Trump signs executive order encouraging research on psychedelic drugs – WCTV](https://cedclinic.com/psychedelic-executive-order-research/) Detailed coverage of the executive order signed by President Trump to promote psychedelic drug research. [Read More](https://cedclinic.com/psychedelic-executive-order-research/) [Trump Signs Order To Accelerate Legal Access To Psychedelics For Patients With Mental …](https://cedclinic.com/accelerate-psychedelic-assisted-therapies-mental-health-access/) Insights into how the executive order aims to speed up legal access to psychedelics for [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) patients. [Learn More](https://cedclinic.com/accelerate-psychedelic-assisted-therapies-mental-health-access/) [Trump signs order to fast-track research on psychedelic drugs | Euronews](https://cedclinic.com/psychedelic-drug-research-acceleration-trump-order/) News on the fast-tracking of psychedelic drug research following the recent executive order. [Explore Article](https://cedclinic.com/psychedelic-drug-research-acceleration-trump-order/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).